Erratum: The inflammatory effects of UDP-glucose in N9 microglia are not mediated by P2Y14 receptor activation (Purinergic Signalling 10.1007/s11302-008-9095-1);The inflammatory effects of UDP-glucose in N9 microglia are not mediated by P2Y14 receptor activation

Purinergic Signalling

Volumn 4, Issue 1, 2008, Pages 73-78

  Brautigam, Vielska M ^a   Dubyak, George R ^b   Crain, Jessica M ^c   Watters, Jyoti J ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Cyclic AMP response element binding protein (CREB); Cyclooxygenase 2 (COX 2); Induciblenitric oxide synthase (iNOS); Microglia; P2Y14; Pertussis toxin (PTX); UD Pgalactose

Indexed keywords

EID: 39649110609     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-008-9101-7     Document Type: Erratum

References (14)

1. Abbracchio MP, Boeynaems J-M, Barnard EA, Boyer JL, Kennedy C, Miras-Portugal MT, King BF, Gachet C, Jacobson KA, Weisman GA, Burnstock G (2003) Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 24(2):52
2. Baker AE, Brautigam VM, Watters JJ (2004) Estrogen modulates microglial inflammatory mediator production via interactions with estrogen receptor {beta}. Endocrinology 145(11):5021-5032
3. Boucsein C, Zacharias R, Farber K, Pavlovic S, Hanisch UK, Kettenmann H (2003) Purinergic receptors on microglial cells: Functional expression in acute brain slices and modulation of microglial activation in vitro. Eur J Neurosci 17(11):2267-2276
4. Brautigam VM, Frasier C, Nikodemova M, Watters JJ (2005) Purinergic receptor modulation of BV-2 microglial cell activity: Potential involvement of p38 MAP kinase and CREB. J Neuroimmunol 166(1-2):113
5. Kobayashi K, Fukuoka T, Iyamanaka H, Dai Y, Obata K, Tokunaga A, Noguchi K (2006) Neurons and glial cells differentially express P2Y receptor mRNAs in the rat dorsal root ganglion and spinal cord. J Comp Neurol 498(4):443-454
6. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685
7. Mitchell JA, Kohlhaas KL, Matsumoto T, Pollock JS, Forstermann U, Warner TD, Schmidt HH, Murad F (1992) Induction of NADPH-dependent diaphorase and nitric oxide synthase activity in aortic smooth muscle and cultured macrophages. Mol Pharmacol 41(6):1163-1168
8. Moore DJ, Murdock PR, Watson JM, Faull RLM, Waldvogel HJ, Szekeres PG, Wilson S, Freeman KB, Emson PC (2003) GPR105, a novel Gi/o-coupled UDP-glucose receptor expressed on brain glia and peripheral immune cells, is regulated by immunologic challenge: Possible role in neuroimmune function. Mol Brain Res 118(1-2):10
9. Righi M, Mori L, De Libero G, Sironi M, Biondi A, Mantovani A, Donini SD, Ricciardi-Castagnoli P (1989) Monokine production by microglial cell clones. Eur J Immunol 19(8):1443-1448
10. Scrivens M, Dickenson JM (2005a) Functional expression of the P2Y14 receptor in murine T-lymphocytes. Br J Pharmacol 146(3):435-444
11. Scrivens M, Dickenson JM (2005b) Pharmacological effects mediated by UDP-glucose that are independent of P2Y14 receptor expression. Pharmacol Res 51(6):533-538
12. Scrivens M, Dickenson JM (2006) Functional expression of the P2Y14 receptor in human neutrophils. Eur J Pharmacol 543(1-3):166
13. Skelton L, Cooper M, Murphy M, Platt A (2003) Human immature monocyte-derived dendritic cells express the G protein-coupled receptor GPR105 (KIAA0001, P2Y14) and increase intracellular calcium in rResponse to its agonist, uridine diphosphoglucose. J Immunol 171(4):1941-1949
14. von Kugelgen I (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110(3):415